[go: up one dir, main page]

WO2009108067A3 - Fatty acid derivatives for use in the prevention and treatment of hsmi - Google Patents

Fatty acid derivatives for use in the prevention and treatment of hsmi Download PDF

Info

Publication number
WO2009108067A3
WO2009108067A3 PCT/NO2009/000069 NO2009000069W WO2009108067A3 WO 2009108067 A3 WO2009108067 A3 WO 2009108067A3 NO 2009000069 W NO2009000069 W NO 2009000069W WO 2009108067 A3 WO2009108067 A3 WO 2009108067A3
Authority
WO
WIPO (PCT)
Prior art keywords
hsmi
prevention
treatment
fatty acid
acid derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/NO2009/000069
Other languages
French (fr)
Other versions
WO2009108067A2 (en
Inventor
Kjell-Arne RØRVIK
Henriette Alne
Magny Thomassen
Rolf Kristian Berge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thia Medica AS
Original Assignee
Thia Medica AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica AS filed Critical Thia Medica AS
Priority to EP09714090A priority Critical patent/EP2257282A2/en
Publication of WO2009108067A2 publication Critical patent/WO2009108067A2/en
Publication of WO2009108067A3 publication Critical patent/WO2009108067A3/en
Anticipated expiration legal-status Critical
Priority to NO20101223A priority patent/NO20101223L/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Insects & Arthropods (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the use of a compound for the preparation of a nutritional and/or pharmaceutical composition for reducing the mortality related to heart and skeletal muscle inflammation (HSMI) of a fish.
PCT/NO2009/000069 2008-02-27 2009-02-27 Prevention and treatment of hsmi Ceased WO2009108067A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP09714090A EP2257282A2 (en) 2008-02-27 2009-02-27 Fatty acid derivatives for use in the prevention and treatment of hsmi
NO20101223A NO20101223L (en) 2008-02-27 2010-09-02 Prevention and treatment of HSMI

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20081040 2008-02-27
NO20081040A NO20081040L (en) 2008-02-27 2008-02-27 Reduced HSMI mortality

Publications (2)

Publication Number Publication Date
WO2009108067A2 WO2009108067A2 (en) 2009-09-03
WO2009108067A3 true WO2009108067A3 (en) 2009-11-12

Family

ID=41003478

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NO2009/000069 Ceased WO2009108067A2 (en) 2008-02-27 2009-02-27 Prevention and treatment of hsmi

Country Status (4)

Country Link
EP (1) EP2257282A2 (en)
CL (1) CL2009000460A1 (en)
NO (2) NO20081040L (en)
WO (1) WO2009108067A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO341929B1 (en) * 2009-09-14 2018-02-19 Chemoforma Ltd Feed composition
NO347765B1 (en) * 2012-11-01 2024-03-18 Ewos Innovation As Feed composition for fish

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005121325A1 (en) * 2004-06-11 2005-12-22 Pharmaq As Heart and skeletal muscle inflammation (hsmi) virus
WO2006009464A2 (en) * 2004-07-19 2006-01-26 Thia Medica As Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
WO2007061314A2 (en) * 2005-11-23 2007-05-31 Berge Biomed As Use of fatty acid analogues

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005121325A1 (en) * 2004-06-11 2005-12-22 Pharmaq As Heart and skeletal muscle inflammation (hsmi) virus
WO2006009464A2 (en) * 2004-07-19 2006-01-26 Thia Medica As Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
WO2007061314A2 (en) * 2005-11-23 2007-05-31 Berge Biomed As Use of fatty acid analogues

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
K-A RØRVIK ET AL.: "Increased survival by feeding tetradecylthioacetic acid during a natural outbreak of heart and skeletal muscle inflammation in S0 Atlantic salmon, Salmo salar L.", JOURNAL OF FISH DISEASES, 10 July 2009 (2009-07-10), pages 1 - 9, XP002543693, Retrieved from the Internet <URL:http://www3.interscience.wiley.com/journal/122508190/abstract?CRETRY=1&SRETRY=0> [retrieved on 20090901] *

Also Published As

Publication number Publication date
EP2257282A2 (en) 2010-12-08
CL2009000460A1 (en) 2010-02-05
NO20081040L (en) 2009-08-28
WO2009108067A2 (en) 2009-09-03
NO20101223L (en) 2010-09-02

Similar Documents

Publication Publication Date Title
WO2011056487A3 (en) Stable thickener formulations
NZ618734A (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
WO2009007412A3 (en) Age deglycation
ZA200903862B (en) Nutritional supplement composition for treatment of ocular diseases
WO2011118976A3 (en) Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same
WO2012074930A3 (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
EP3228311A3 (en) Pharmaceutical and nutraceutical compositions of abscisic acid
MY159492A (en) Solid pharmaceutical formulation with delayed release
WO2013028555A3 (en) Methods for weight loss and ketogenic compositions
GEP20125464B (en) Dha esters and use thereof in treatment and prevention of cardiovascular disease
WO2010087565A3 (en) Novel use of piperine
HRP20240115T1 (en) Increasing drug bioavailability in naltrexone therapy
WO2011077163A3 (en) Use
ZA201003764B (en) Mixed butyric-formic esters of acid polysaccharides, and their preparation and use as skin cosmetics
WO2007107008A8 (en) Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity
WO2011031166A3 (en) Fish feed
WO2012064159A3 (en) Anticancer composition
WO2009061152A3 (en) Composition for prevention and treatment of pain containing curcumin or pharmaceutically acceptable salt thereof as an active ingredient
WO2009108067A3 (en) Fatty acid derivatives for use in the prevention and treatment of hsmi
WO2011118957A3 (en) Composition for treating inflammatory, allergic or asthma diseases, containing paprika extracts
WO2008116737A3 (en) Capsule containing plant preparations
WO2009150257A3 (en) Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
WO2005051290A8 (en) Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone
WO2009104900A3 (en) Composition comprising a flower extract of lonicera japonica thunb for preventing and treating arthritic diseases
WO2008152333A3 (en) Novel derivatives of 3-phenyl propanoic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09714090

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009714090

Country of ref document: EP